Group One Trading
NGNE icon

Group One Trading’s Neurogene NGNE Stock Holding History

Group One Trading’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-88,800
Closed -$1.54M – 8820
2025
Q3 		$1.54M Buy
88,800
+87,100
+5,124% +$1.75M ﹤0.01% 2580
2025
Q2 		$25.4K Buy
1,700
+600
+55% +$9.41K ﹤0.01% 6109
2025
Q1 		$12.9K Sell
1,100
-9,500
-90% -$165K ﹤0.01% 6100
2024
Q4 		$242K Buy
+10,600
New +$394K ﹤0.01% 3788
2024
Q1 		– Sell
-200
Closed -$3.88K – 7669
2023
Q4 		$3.88K Buy
+200
New +$2.86K ﹤0.01% 6609
2022
Q2 		– Sell
-125
Closed -$5K – 8268
2022
Q1 		$5K Sell
125
-60
-32% -$3.5K ﹤0.01% 7466
2021
Q4 		$18K Buy
+185
New +$22.5K ﹤0.01% 7034
2021
Q3 		– Sell
-65
Closed -$12K – 8571
2021
Q2 		$12K Sell
65
-25
-28% -$5.53K ﹤0.01% 7450
2021
Q1 		$22K Sell
90
-35
-28% -$8.95K ﹤0.01% 6722
2020
Q4 		$35K Buy
125
+90
+257% +$22K ﹤0.01% 5221
2020
Q3 		$8K Sell
35
-65
-65% -$15.7K ﹤0.01% 5500
2020
Q2 		$33K Sell
100
-765
-88% -$199K ﹤0.01% 4591
2020
Q1 		$197K Buy
865
+765
+765% +$157K ﹤0.01% 2762
2019
Q4 		$25K Buy
100
+90
+900% +$8.96K ﹤0.01% 4286
2019
Q3 		$1K Sell
10
-85
-89% -$5.19K ﹤0.01% 4995
2019
Q2 		$4K Sell
95
-30
-24% -$1.54K ﹤0.01% 4644
2019
Q1 		$7K Buy
125
+95
+317% +$4.8K ﹤0.01% 4370
2018
Q4 		$1K Sell
30
-695
-96% -$33.9K ﹤0.01% 4740
2018
Q3 		$42K Sell
725
-55
-7% -$3.24K ﹤0.01% 4069
2018
Q2 		$41K Buy
780
+730
+1,460% +$190K ﹤0.01% 4057
2018
Q1 		$14K Sell
50
-835
-94% -$231K ﹤0.01% 4211
2017
Q4 		$208K Buy
885
+775
+705% +$182K ﹤0.01% 2901
2017
Q3 		$31K Sell
110
-270
-71% -$77.5K ﹤0.01% 3858
2017
Q2 		$107K Buy
+380
New +$109K ﹤0.01% 3065
2016
Q4 		– Sell
-140
Closed -$37K – 4686
2016
Q3 		$37K Buy
+140
New +$28.2K ﹤0.01% 3509

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Group One Trading's NGNE Position: Q1 2024 in Review

Group One Trading sold out of Neurogene (NGNE) in Q1 2024, closing a stake of 74 shares — an estimated $1.43K sold.

Group One Trading first reported a position in NGNE in Q3 2016 and held it in 16 quarters. The position peaked at $200K in Q1 2017. 60 funds tracked by Wall St. Rank hold NGNE as of Q1 2024.

  • Group One Trading reported no remaining Neurogene position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 74 Neurogene shares in Q1 2024, an estimated $1.43K.
  • Group One Trading first reported a position in Neurogene in Q3 2016 and held it in 16 quarters.
  • Group One Trading's Neurogene position peaked at $200K in Q1 2017.
  • 60 funds tracked by Wall St. Rank held Neurogene as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.